Mandate

Vinge advises Balticgruppen AB in connection with real estate transaction with Västerbottens-Kurirens AB

September 21, 2009

Vinge is advising Balticgruppen AB in connection with the formation of real estate company in Umeå which will be jointly owned with Västerbottens-Kurirens AB. The new company, Fastighetsbolaget Kuriren AB, will be a 50/50 joint venture between Balticgruppen AB and Västerbottens-Kurirens AB. Both Balticgruppen AB and Västerbottens-Kurirens AB will be selling properties to the jointly-owned company which will include Umedlasparken, Vita Husen, VK-Huset, Uminova Husen, Patienthotellet Björken and Vårdvetarhuset, all of which are situated in Umeå. In total, the new company will own properties with a total area of 130,000 sq.m. Completion will take place in January 2010. The properties will be managed by Balticgruppen Fastighet AB on behalf of Fastighetsbolaget Kuriren AB.

Vinge’s team advising Balticgruppen AB consists of partners Jan Widlund and Patrick Forslund together with, among others, associate Jenny Dangré. Tax advice is being provided by partner Lennart Larsson and associate Johan Norström.

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025